公开(公告)号：US20150119400A1

公开(公告)日：2015-04-30

申请号：US14523692

申请日：2014-10-24

Applicant: AbbVie, Inc.

Inventor： Iok C. Ng ,  Liangjun Lu ,  Tanya Dekhtyar ,  Thomas Reisch ,  Rakesh L. Tripathi ,  Ron Pithawalla ,  Christine A. Collins ,  Tami J. Pilot-Matias

IPC: A61K31/498 ,  A61K45/06

CPC classification number: A61K31/498 ,  A61K31/7056 ,  A61K45/06 ,  A61K2300/00

Abstract: Pan-genotypic HCV inhibitors are described. This invention also relates to methods of using these inhibitors to treat HCV infection.

Abstract translation: 描述了泛基因型HCV抑制剂。 本发明还涉及使用这些抑制剂治疗HCV感染的方法。

公开(公告)号：US11639390B2

公开(公告)日：2023-05-02

申请号：US17378565

申请日：2021-07-16

Applicant: AbbVie Inc.

Inventor： Jing Min ,  Teresa (Iok-Chan) Ng ,  Lorenzo Benatuil ,  Jacqueline Bixby ,  Tatyana Dekhtyar ,  Feng Dong ,  Axel Hernandez, Jr. ,  Preethi Krishnan ,  Liangjun Lu ,  Federico Mensa ,  Renee Miller ,  Gautam Sahu

IPC: C12N5/02 ,  C12N5/20 ,  C12N1/20 ,  C12N15/00 ,  C07K16/46 ,  C07K16/00 ,  C07H21/04 ,  C07K16/28 ,  A61P31/18 ,  C12N15/63 ,  A61K39/00

Abstract: The present disclosure provides anti-α4β7 antibodies that bind human α4β7, their methods of making, and their uses to treat patients with HIV infection.

公开(公告)号：US20220017624A1

公开(公告)日：2022-01-20

申请号：US17378565

申请日：2021-07-16

Applicant: AbbVie Inc.

Inventor： Jing Min ,  Teresa (Iok-Chan) Ng ,  Lorenzo Benatuil ,  Jacqueline Bixby ,  Tatyana Dekhtyar ,  Feng Dong ,  Axel Hernandez, Jr. ,  Preethi Krishnan ,  Liangjun Lu ,  Federico Mensa ,  Renee Miller ,  Gautam Sahu

IPC: C07K16/28 ,  A61P31/18 ,  C12N15/63

Abstract: The present disclosure provides anti-α4β7 antibodies that bind human α4β7, their methods of making, and their uses to treat patients with HIV infection.